C Partners Holding’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.4M Sell
27,956
-521
-2% -$310K 5.14% 7
2026
Q2
$14.3M Sell
28,477
-36,885
-56% -$17.7M 4.33% 8
2026
Q1
$32.1M Buy
65,362
+10,963
+20% +$5.95M 10.14% 6
2025
Q4
$31.5M Sell
54,399
-5,044
-8% -$2.85M 8.48% 6
2025
Q3
$28.8M Sell
59,443
-20,921
-26% -$9.7M 7.56% 8
2025
Q2
$32.6M Buy
80,364
+36,630
+84% +$15.3M 7.16% 8
2025
Q1
$21.8M Buy
+43,734
New +$23.7M 5.68% 9
2015
Q3
– Sell
-6,300
Closed -$817K – 33
2015
Q2
$817K Hold
6,300
– – 0.38% 37
2015
Q1
$846K Hold
6,300
– – 0.27% 41
2014
Q4
$789K Buy
+6,300
New +$766K 0.26% 43

Other funds holding TMO

C Partners Holding's TMO Position: Q3 2026 in Review

C Partners Holding reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q3 2026, selling an estimated $310K and leaving 27,956 shares worth $17.4M. The position accounts for 5.14% of the portfolio, ranked #7.

C Partners Holding first reported a position in TMO in Q4 2014 and has held it in 10 quarters since. The position peaked at $32.6M in Q2 2025. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • C Partners Holding held 27,956 shares of Thermo Fisher Scientific worth $17.4M as of Q3 2026.
  • C Partners Holding sold 521 Thermo Fisher Scientific shares in Q3 2026, an estimated $310K.
  • Thermo Fisher Scientific made up 5.14% of C Partners Holding's portfolio in Q3 2026, its #7 holding.
  • C Partners Holding first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 10 quarters since.
  • C Partners Holding's Thermo Fisher Scientific position peaked at $32.6M in Q2 2025.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on C Partners Holding's 13F filing for Q3 2026, filed 16 Nov 2026.